ArticleInternational journal of general medicine2026
Potential Ferroptosis-Related Genes and Immune Infiltration in Form-Deprivation Myopia: An Integrative Bioinformatics and in vitro Validation Study.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanistic Study of m5C Modification in Stem Cell Differentiation and Disease Regulation.Stem cell reviews and reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to explore the molecular mechanisms of form-deprivation myopia (FDM) by identifying potential ferroptosis-related genes (FRGs) and characterizing the immune infiltration landscape, with the goal of providing preliminary insights that may inform future research on diagnostic or therapeutic candidates. Methods: Transcriptomic data from GSE223434 (training set) and GSE210238 (validation set) were analyzed to identify differentially expressed FRGs (FRDEGs). Weighted gene co-expression network analysis (WGCNA) and machine learning algorithms, including LASSO regression and Random Forest, were employed to screen for hub genes. Immune infiltration was assessed using the CIBERSORT algorithm. Finally, the functional roles of hub genes were validated in vitro using TGF-β2-induced human scleral fibroblasts (HSFs) and siRNA-mediated knockdown experiments. Results: A total of 256 FRDEGs were identified in FDM retinas. Three hub genes PRKAA1, TGFB3, and WWTR1, were selected and showed preliminary diagnostic potential value, with AUCs reaching 0.750, 0.725, and 0.762 in the training set. Immune analysis revealed significant differences in monocyte infiltration between myopia and control groups. In vitro assays confirmed that TGF-β2 treatment significantly elevated the expression of these hub genes and reduced GPX4 levels, while the ferroptosis inhibitor ferrostatin-1 (Fer-1) reversed these effects. Furthermore, silencing PRKAA1, WWTR1, or TGFB3 promoted ferroptosis and fibrotic markers, which were significantly rescued by Fer-1 intervention. Conclusion: The identified ferroptosis-immune axis, centered on PRKAA1, TGFB3, and WWTR1, may play a role in the pathogenesis of myopia. These hub genes represent candidate molecules that warrant further investigation as potential diagnostic markers, and they provide a preliminary biological perspective for understanding myopic scleral remodeling in the context of ferroptosis regulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.